Generic Semaglutide hits India: Prices fall 90% as companies compete for diabetic patients
A drug that cost over Rs 10,000 a month is now available for as little as Rs 220 a shot. Multiple companies have entered the market on Day 1 with different prices, formats and strategies, competing for a patient base that runs into the millions but remains largely untreated.
A drug that cost over Rs 10,000 a month is now available for as little as Rs 220 a shot. Multiple companies have entered the market on Day 1 with different prices, formats and strategies, competing for a patient base that runs into the millions but remains largely untreated.
What's Your Reaction?
DDP Editor
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
